154 related articles for article (PubMed ID: 20097777)
1. Subcellular localization of mu-opioid receptor G(s) signaling.
Chakrabarti S; Chang A; Gintzler AR
J Pharmacol Exp Ther; 2010 Apr; 333(1):193-200. PubMed ID: 20097777
[TBL] [Abstract][Full Text] [Related]
2. Chronic opioid treatment augments caveolin-1 scaffolding: relevance to stimulatory μ-opioid receptor adenylyl cyclase signaling.
Chakrabarti S; Chang A; Liu NJ; Gintzler AR
J Neurochem; 2016 Dec; 139(5):737-747. PubMed ID: 27726130
[TBL] [Abstract][Full Text] [Related]
3. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA
Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820
[TBL] [Abstract][Full Text] [Related]
4. Agonist activity of naloxone benzoylhydrazone at recombinant and native opioid receptors.
Olianas MC; Concas D; Onali P
Br J Pharmacol; 2006 Feb; 147(4):360-70. PubMed ID: 16402046
[TBL] [Abstract][Full Text] [Related]
5. Agonist treatment did not affect association of mu opioid receptors with lipid rafts and cholesterol reduction had opposite effects on the receptor-mediated signaling in rat brain and CHO cells.
Huang P; Xu W; Yoon SI; Chen C; Chong PL; Unterwald EM; Liu-Chen LY
Brain Res; 2007 Dec; 1184():46-56. PubMed ID: 17980352
[TBL] [Abstract][Full Text] [Related]
6. Biochemical demonstration of mu-opioid receptor association with Gsalpha: enhancement following morphine exposure.
Chakrabarti S; Regec A; Gintzler AR
Brain Res Mol Brain Res; 2005 Apr; 135(1-2):217-24. PubMed ID: 15857684
[TBL] [Abstract][Full Text] [Related]
7. Specific activation of the mu opioid receptor (MOR) by endomorphin 1 and endomorphin 2.
Monory K; Bourin MC; Spetea M; Tömböly C; Tóth G; Matthes HW; Kieffer BL; Hanoune J; Borsodi A
Eur J Neurosci; 2000 Feb; 12(2):577-84. PubMed ID: 10712637
[TBL] [Abstract][Full Text] [Related]
8. Dual effects of DAMGO [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin and CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2) on adenylyl cyclase activity: implications for mu-opioid receptor Gs coupling.
Szücs M; Boda K; Gintzler AR
J Pharmacol Exp Ther; 2004 Jul; 310(1):256-62. PubMed ID: 14996951
[TBL] [Abstract][Full Text] [Related]
9. Caveolin-1 and lipid microdomains regulate Gs trafficking and attenuate Gs/adenylyl cyclase signaling.
Allen JA; Yu JZ; Dave RH; Bhatnagar A; Roth BL; Rasenick MM
Mol Pharmacol; 2009 Nov; 76(5):1082-93. PubMed ID: 19696145
[TBL] [Abstract][Full Text] [Related]
10. CB1 receptor-independent actions of SR141716 on G-protein signaling: coapplication with the mu-opioid agonist Tyr-D-Ala-Gly-(NMe)Phe-Gly-ol unmasks novel, pertussis toxin-insensitive opioid signaling in mu-opioid receptor-Chinese hamster ovary cells.
Cinar R; Szücs M
J Pharmacol Exp Ther; 2009 Aug; 330(2):567-74. PubMed ID: 19448142
[TBL] [Abstract][Full Text] [Related]
11. Plasticity of adenylyl cyclase-related signaling sequelae after long-term morphine treatment.
Shy M; Chakrabarti S; Gintzler AR
Mol Pharmacol; 2008 Mar; 73(3):868-79. PubMed ID: 18045853
[TBL] [Abstract][Full Text] [Related]
12. Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor.
Emmerson PJ; Clark MJ; Mansour A; Akil H; Woods JH; Medzihradsky F
J Pharmacol Exp Ther; 1996 Sep; 278(3):1121-7. PubMed ID: 8819494
[TBL] [Abstract][Full Text] [Related]
13. mu-Opioid receptor-stimulated guanosine-5'-O-(gamma-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacy.
Selley DE; Sim LJ; Xiao R; Liu Q; Childers SR
Mol Pharmacol; 1997 Jan; 51(1):87-96. PubMed ID: 9016350
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel "almost neutral" micro-opioid receptor antagonist in CHO cells expressing the cloned human mu-opioid receptor.
Sally EJ; Xu H; Dersch CM; Hsin LW; Chang LT; Prisinzano TE; Simpson DS; Giuvelis D; Rice KC; Jacobson AE; Cheng K; Bilsky EJ; Rothman RB
Synapse; 2010 Apr; 64(4):280-8. PubMed ID: 19953652
[TBL] [Abstract][Full Text] [Related]
15. Signal transduction correlates of mu opioid agonist intrinsic efficacy: receptor-stimulated [35S]GTP gamma S binding in mMOR-CHO cells and rat thalamus.
Selley DE; Liu Q; Childers SR
J Pharmacol Exp Ther; 1998 May; 285(2):496-505. PubMed ID: 9580589
[TBL] [Abstract][Full Text] [Related]
16. ABIN-1 Negatively Regulates
Zhou P; Jiang J; Yan H; Li Y; Zhao J; Wang X; Su R; Gong Z
Mol Pharmacol; 2018 Feb; 93(2):36-48. PubMed ID: 29237725
[TBL] [Abstract][Full Text] [Related]
17. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
Liu JG; Prather PL
Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600
[TBL] [Abstract][Full Text] [Related]
18. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study.
Newman-Tancredi A; Cussac D; Audinot V; Pasteau V; Gavaudan S; Millan MJ
Mol Pharmacol; 1999 Mar; 55(3):564-74. PubMed ID: 10051542
[TBL] [Abstract][Full Text] [Related]
19. Basal signaling activity of mu opioid receptor in mouse brain: role in narcotic dependence.
Wang D; Raehal KM; Lin ET; Lowery JJ; Kieffer BL; Bilsky EJ; Sadée W
J Pharmacol Exp Ther; 2004 Feb; 308(2):512-20. PubMed ID: 14600246
[TBL] [Abstract][Full Text] [Related]
20. Nucleoside diphosphate kinase associated with membranes modulates mu-opioid receptor-mediated [35S]GTPgammaS binding and agonist binding to mu-opioid receptor.
Zhang D; Li JG; Chen C; Liu-Chen LY
Eur J Pharmacol; 1999 Jul; 377(2-3):223-31. PubMed ID: 10456435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
